- Home
- ANNX vs SNBR Comparison
ANNX vs SNBR Comparison
Compare ANNX & SNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- SNBR
- Stock Information
- Founded
- ANNX 2011
- SNBR 1987
- Country
- ANNX United States
- SNBR United States
- Employees
- ANNX N/A
- SNBR N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- SNBR Home Furnishings
- Sector
- ANNX Health Care
- SNBR Consumer Discretionary
- Exchange
- ANNX Nasdaq
- SNBR Nasdaq
- Market Cap
- ANNX 362.4M
- SNBR 399.8M
- IPO Year
- ANNX 2020
- SNBR 1998
- Fundamental
- Price
- ANNX $1.60
- SNBR $7.99
- Analyst Decision
- ANNX Strong Buy
- SNBR Hold
- Analyst Count
- ANNX 5
- SNBR 2
- Target Price
- ANNX $18.67
- SNBR $9.00
- AVG Volume (30 Days)
- ANNX 1.6M
- SNBR 776.2K
- Earning Date
- ANNX 05-20-2025
- SNBR 04-30-2025
- Dividend Yield
- ANNX N/A
- SNBR N/A
- EPS Growth
- ANNX N/A
- SNBR N/A
- EPS
- ANNX N/A
- SNBR N/A
- Revenue
- ANNX N/A
- SNBR $1,605,108,000.00
- Revenue This Year
- ANNX N/A
- SNBR N/A
- Revenue Next Year
- ANNX N/A
- SNBR $4.19
- P/E Ratio
- ANNX N/A
- SNBR N/A
- Revenue Growth
- ANNX N/A
- SNBR N/A
- 52 Week Low
- ANNX $1.29
- SNBR $4.48
- 52 Week High
- ANNX $7.85
- SNBR $20.75
- Technical
- Relative Strength Index (RSI)
- ANNX 38.84
- SNBR 60.51
- Support Level
- ANNX $1.62
- SNBR $6.63
- Resistance Level
- ANNX $2.01
- SNBR $8.61
- Average True Range (ATR)
- ANNX 0.13
- SNBR 0.65
- MACD
- ANNX 0.01
- SNBR 0.24
- Stochastic Oscillator
- ANNX 0.00
- SNBR 80.32
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.